Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
==========================================================================================================================================================================================

* Young Kwang Chae
* Ayush Arya
* Wade Iams
* Marcelo R. Cruz
* Sunandana Chandra
* Jaehyuk Choi
* Francis Giles